 |
|
Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration
Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
J Korean Ophthalmol Soc. 2021;62(8):1076-1083. Published online 2021 Aug 15 DOI: https://doi.org/10.3341/jkos.2021.62.8.1076
|
|
Citations to this article as recorded by
 Short-term Anatomical Outcomes of Switching from Bevacizumab to the Ranibizumab Biosimilar CKD-701 in Neovascular Age-related Macular Degeneration
Yi Sang Yoon, Jae Hui Kim
Journal of Retina.2024; 9(2): 127. CrossRef Analyzing Treatment Patterns for Neovascular Age-related Macular Degeneration with Expansion of the Korean Health Insurance Policy
Young Min Park, Kang Ju Son, Eun Jee Chung, Seo Hee Kim
Journal of the Korean Ophthalmological Society.2023; 64(10): 913. CrossRef
|